CLASS 2 RECALL - XOMOLIX 2.5MG/ML SOLUTION FOR INJECTION

Kyowa Kirin Limited is recalling the below batches as a precautionary measure, due to the reports of glass and cellulose fibre contamination, which was identified during stability and reference sample inspection

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-kyowa-kirin-limited-xomolix-2-dot-5-mg-slash-ml-solution-for-injection-el-21-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications&utm_source=3e23300a-19ec-459c-9311-e77b781e4d45&utm_content=immediately   

Further information

For Stock control enquiries please contact

Karen Murray, Commercial Manager

Telephone: +44 (0) 1896 661665 / Mobile: +44 (0) 7712 001288

Email: karen.murray@kyowakirin.com

For Medical information enquiries please contact

Medical Information Direct Line: + 44 (0)1896 664 000

Email: medinfo@kyowakirin.com

For Quality information please contact

Martin Smith (Responsible Person)

Telephone: Mobile: +44 7904671807

Email: Martin.Smith@kyowakirin.com.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit..

If you have any questions, then please contact your local Service Centre Customer Services team.